BE802231A - Omega-pentaorprostaglandines substituees en position 15 - Google Patents

Omega-pentaorprostaglandines substituees en position 15

Info

Publication number
BE802231A
BE802231A BE1005234A BE1005234A BE802231A BE 802231 A BE802231 A BE 802231A BE 1005234 A BE1005234 A BE 1005234A BE 1005234 A BE1005234 A BE 1005234A BE 802231 A BE802231 A BE 802231A
Authority
BE
Belgium
Prior art keywords
pentaorprostaglandins
omega
substituted
pentaorprostaglandins substituted
Prior art date
Application number
BE1005234A
Other languages
English (en)
French (fr)
Inventor
M R Johnson
H-J E Hess
T K Schaaf
J S Bindra
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BE802231A publication Critical patent/BE802231A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056Esters of arylalkanephosphonic acids
    • C07F9/4059Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
    • C07F9/655345Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B63SHIPS OR OTHER WATERBORNE VESSELS; RELATED EQUIPMENT
    • B63BSHIPS OR OTHER WATERBORNE VESSELS; EQUIPMENT FOR SHIPPING 
    • B63B2211/00Applications
    • B63B2211/02Oceanography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
BE1005234A 1972-07-13 1973-07-12 Omega-pentaorprostaglandines substituees en position 15 BE802231A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27122072A 1972-07-13 1972-07-13

Publications (1)

Publication Number Publication Date
BE802231A true BE802231A (fr) 1974-01-14

Family

ID=23034697

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1005234A BE802231A (fr) 1972-07-13 1973-07-12 Omega-pentaorprostaglandines substituees en position 15

Country Status (25)

Country Link
JP (4) JPS5241257B2 (xx)
AR (2) AR209064A1 (xx)
AT (1) AT367033B (xx)
BE (1) BE802231A (xx)
CA (1) CA1041495A (xx)
CH (1) CH593254A5 (xx)
CS (1) CS201027B2 (xx)
DD (2) DD109210A5 (xx)
DE (1) DE2334945A1 (xx)
ES (4) ES416865A1 (xx)
FI (1) FI57583C (xx)
FR (1) FR2192834B1 (xx)
GB (1) GB1446341A (xx)
HU (4) HU171158B (xx)
IE (1) IE37909B1 (xx)
IL (2) IL42691A (xx)
IN (1) IN138789B (xx)
LU (1) LU68015A1 (xx)
NL (1) NL7309792A (xx)
NO (2) NO143741C (xx)
PH (1) PH11461A (xx)
SE (3) SE7705947L (xx)
SU (4) SU644384A3 (xx)
YU (1) YU187773A (xx)
ZA (1) ZA734769B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1386146A (en) * 1972-05-03 1975-03-05 Ici Ltd Cyclopentane derivatives
DE2463432C2 (xx) * 1974-04-03 1987-06-19 Hoechst Ag, 6230 Frankfurt, De
DE2416193C2 (de) 1974-04-03 1985-08-14 Hoechst Ag, 6230 Frankfurt Prostaglandin-Analoge, Verfahren zu ihrer Herstellung sowie ihre Verwendung als cytoprotektives Mittel
ZA747723B (en) * 1974-12-11 1976-11-24 Pfizer 11-desoxy-15-substituted-omega-pentanor prostaglandins
US4149006A (en) * 1977-01-24 1979-04-10 G. D. Searle & Co. Prostaglandin derivatives having alkynyl, hydroxy and aryloxy junctions in the 2β side chain
GB8329559D0 (en) * 1983-11-04 1983-12-07 Erba Farmitalia Furyl derivatives of 16-substituted prostaglandins preparations
SE9002596D0 (sv) * 1990-08-08 1990-08-08 Pharmacia Ab A method for synthesis of prostaglandin derivatives
US6602900B2 (en) 1992-09-21 2003-08-05 Allergan, Inc. Cyclopentane heptan(ENE)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US5972991A (en) * 1992-09-21 1999-10-26 Allergan Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
KR100578616B1 (ko) * 2004-07-23 2006-05-10 한미약품 주식회사 D-에리트로-2,2-다이플루오로-2-데옥시-1-옥소라이보스화합물의 제조방법
BR112016013594A8 (pt) * 2013-12-13 2020-05-19 Allergan Inc formas cristalinas de um composto dihidroxi ciclopentil alfa, ômega-dissubstituído, composição farmacêutica, métodos para o preparo e uso das mesmas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1324737A (en) * 1970-11-02 1973-07-25 Upjohn Co Prostaglandins and the preparation thereof
GB1386146A (en) * 1972-05-03 1975-03-05 Ici Ltd Cyclopentane derivatives
IL42373A (en) * 1972-06-02 1977-08-31 Pfizer Oxaprostagliandins and their preparation

Also Published As

Publication number Publication date
JPS4992053A (xx) 1974-09-03
AR214383A1 (es) 1979-06-15
SE7705946L (sv) 1977-05-20
ZA734769B (en) 1974-06-26
ES437038A1 (es) 1977-01-01
SU645564A3 (ru) 1979-01-30
SE7705945L (sv) 1977-05-20
DD109210A5 (xx) 1974-10-20
IL42691A0 (en) 1973-10-25
AT367033B (de) 1982-05-25
ES437039A1 (es) 1977-01-01
DD116459A5 (xx) 1975-11-20
IL42691A (en) 1979-07-25
FR2192834A1 (xx) 1974-02-15
CS201027B2 (en) 1980-10-31
CA1041495A (en) 1978-10-31
NL7309792A (xx) 1974-01-15
JPS5297958A (en) 1977-08-17
HU172058B (hu) 1978-05-28
ES416865A1 (es) 1976-03-01
SE7705947L (sv) 1977-05-20
IN138789B (xx) 1976-04-03
PH11461A (en) 1978-02-01
AR209064A1 (es) 1977-03-31
SU584791A3 (ru) 1977-12-15
JPS52122349A (en) 1977-10-14
FR2192834B1 (xx) 1979-04-06
HU171156B (hu) 1977-11-28
ATA620773A (de) 1981-10-15
NO143741C (no) 1981-04-08
JPS5293753A (en) 1977-08-06
JPS5241257B2 (xx) 1977-10-17
HU171158B (hu) 1977-11-28
IE37909L (en) 1974-01-13
HU171946B (hu) 1978-04-28
IE37909B1 (en) 1977-11-09
YU187773A (en) 1982-02-25
NO144830B (no) 1981-08-10
SU644384A3 (ru) 1979-01-25
AU5778473A (en) 1975-01-09
CH593254A5 (xx) 1977-11-30
LU68015A1 (xx) 1974-01-21
GB1446341A (en) 1976-08-18
SU645563A3 (ru) 1979-01-30
NO144830C (no) 1981-11-18
IL50308A0 (en) 1976-10-31
FI57583B (fi) 1980-05-30
FI57583C (fi) 1980-09-10
NO143741B (no) 1980-12-29
ES437037A1 (es) 1977-01-01
NO743492L (no) 1974-01-15
DE2334945A1 (de) 1974-03-07

Similar Documents

Publication Publication Date Title
FI53333C (fi) Torkningscylindergrupp i en flercylindertork foer en materialbana i synnerhet foer papper
AT324072B (de) Wendelbohreb
FI56449B (fi) Vingstabiliserad projektil
AT343071B (de) Reissverschluss
AT332834B (de) Reissverschluss
AT323930B (de) Untermatratze
BE802231A (fr) Omega-pentaorprostaglandines substituees en position 15
IT1045864B (it) Accouplement d'ambre
IT989076B (it) 1 2 diazaciclododecani non saturi
BE801110A (fr) 1,2,3,4-tetrahydroanthraquinones alcoylees en position 2
AT340851B (de) Reissverschluss
BR7305663D0 (pt) Aperfeicoamentos em percompostos particulares
SE393963B (sv) I brevlador instoppbar ask
IT991152B (it) Azocoloranti basici
BE792772A (fr) Elements d'ameublement
FI55561C (fi) Oeverladdad foerbraenningsmotor i synnerhet oeverladdad dieselmotor
AT322779B (de) Bücherbrett
BE787372A (fr) 2-nitroamino-6-hydroxy-4-methylpyrimidines substituees en position 5
BE801111A (fr) 1,2,3,4-tetrahydroanthraquinones alcoylees en position 1
BE793171A (fr) Composition d'email-glacure
AT340852B (de) Reissverschluss
FI56543B (fi) Foerfarande foer framstaellning i pastaframstaellning anvaendbara vinylkloridkopolymerisatpulver
SE7214374L (sv) Rotel 205
BR7303900D0 (pt) Aperfeicoamentos em encinerador de detritos
TR17502A (tr) Herbisid terkip